文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛心脑血管急症

早期与标准气管切开策略对接受机械通气的重症卒中患者6个月功能结局的影响:SETPOINT2随机临床试验

Effect of Early vs Standard Approach to Tracheostomy on Functional Outcome at 6 Months Among Patients With Severe Stroke Receiving Mechanical Ventilation: The SETPOINT2 Randomized Clinical Trial.
PubMed 文献 · JAMA · 2022-01-01
一句话结论重症卒中机械通气患者中,早期气管切开(≤5天)较标准策略(必要时第10天起)未显著改善6个月无严重残疾生存率(43.5% vs 47.1%,P=0.73),但宽置信区间不能排除临床相关获益或危害。

SETPOINT2为在美国和德国26个神经重症中心开展的随机临床试验,纳入382例接受有创通气的重症急性缺血性或出血性卒中患者,1:1随机分为早期气管切开策略(插管≤5天,n=188)与标准策略(继续脱机,必要时第10天起气管切开,n=194)。主要终点为6个月改良Rankin量表评分0-4分(无严重残疾)的比例,早期组43.5% vs 对照组47.1%,差异-3.6%(95%CI -14.3%至7.2%),校正OR 0.93(95%CI 0.60-1.42),P=0.73,无显著差异。气管切开相关严重不良事件早期组5.0%(6/121)vs 对照组3.4%(4/118)。结论认为早期气管切开未显著改善无严重残疾生存率,但宽置信区间不能排除临床相关获益或危害。

要点

  • 重症卒中机械通气患者早期气管切开(≤5天)与标准策略(必要时第10天起)6个月mRS 0-4分比例无显著差异:43.5% vs 47.1%,差异-3.6%(95%CI -14.3%至7.2%),校正OR 0.93(95%CI 0.60-1.42),P=0.73。
  • 早期组95.2%在中位插管后4天(IQR 3-4天)行气管切开(多为经皮),对照组67%在中位插管后11天(IQR 10-12天)行气管切开。
  • 气管切开相关严重不良事件早期组5.0%(6/121起报告事件) vs 对照组3.4%(4/118起报告事件)。
  • 作者结论:早期气管切开未显著改善6个月无严重残疾生存率,但宽置信区间可能包含临床重要差异,不能排除临床相关获益或危害。

适用人群与场景

  • 重症急性缺血性或出血性卒中接受有创机械通气的患者,中位年龄59岁,49.8%女性。
  • 研究在26个美国与德国神经重症中心开展,随机时间2015年7月28日至2020年1月24日,末次随访2020年8月9日。

处置流程与药物剂量

  • 早期气管切开策略:插管≤5天行气管切开(n=188),实际95.2%在中位插管后4天(IQR 3-4天)完成,多为经皮气管切开。
  • 标准策略(对照组):继续呼吸机脱机,必要时从第10天起行气管切开(n=194),实际67%在中位插管后11天(IQR 10-12天)完成。

研究设计与关键结果

  • 随机临床试验,382例重症卒中机械通气患者,26个中心,1:1随机分为早期气管切开组(n=188)与标准气管切开对照组(n=194)。
  • 366例(95.8%)完成试验并有主要终点随访数据(早期组177例[94.1%],标准组189例[97.4%])。
  • 主要终点6个月mRS 0-4分(无严重残疾)比例:早期组43.5% vs 对照组47.1%,差异-3.6%(95%CI -14.3%至7.2%),校正OR 0.93(95%CI 0.60-1.42),P=0.73。
  • 气管切开相关严重不良事件:早期组5.0%(6/121起报告事件) vs 对照组3.4%(4/118起报告事件)。

证据类型、等级与局限

  • 证据类型:随机临床试验(SETPOINT2,ClinicalTrials.gov NCT02377167)。
  • 局限:原文报告效应估计的置信区间宽,可能包含临床重要差异,因此不能排除早期气管切开策略的临床相关获益或危害。

对床旁实践的改变

  • 对于重症卒中接受机械通气的患者,早期气管切开策略(≤5天)与标准策略(必要时第10天起)相比,未显著改善6个月无严重残疾生存率;作者认为宽置信区间不能排除临床相关获益或危害。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Many patients with severe stroke have impaired airway protective reflexes, resulting in prolonged invasive mechanical ventilation.

OBJECTIVE: To test whether early vs standard tracheostomy improved functional outcome among patients with stroke receiving mechanical ventilation.

DESIGN, SETTING, AND PARTICIPANTS: In this randomized clinical trial, 382 patients with severe acute ischemic or hemorrhagic stroke receiving invasive ventilation were randomly assigned (1:1) to early tracheostomy (≤5 days of intubation) or ongoing ventilator weaning with standard tracheostomy if needed from day 10. Patients were randomized between July 28, 2015, and January 24, 2020, at 26 US and German neurocritical care centers. The final date of follow-up was August 9, 2020.

INTERVENTIONS: Patients were assigned to an early tracheostomy strategy (n = 188) or to a standard tracheostomy (control group) strategy (n = 194).

MAIN OUTCOMES AND MEASURES: The primary outcome was functional outcome at 6 months, based on the modified Rankin Scale score (range, 0 [best] to 6 [worst]) dichotomized to a score of 0 (no disability) to 4 (moderately severe disability) vs 5 (severe disability) or 6 (death).

RESULTS: Among 382 patients randomized (median age, 59 years; 49.8% women), 366 (95.8%) completed the trial with available follow-up data on the primary outcome (177 patients [94.1%] in the early group; 189 patients [97.4%] in the standard group). A tracheostomy (predominantly percutaneously) was performed in 95.2% of the early tracheostomy group in a median of 4 days after intubation (IQR, 3-4 days) and in 67% of the control group in a median of 11 days after intubation (IQR, 10-12 days). The proportion without severe disability (modified Rankin Scale score, 0-4) at 6 months was not significantly different in the early tracheostomy vs the control group (43.5% vs 47.1%; difference, -3.6% [95% CI, -14.3% to 7.2%]; adjusted odds ratio, 0.93 [95% CI, 0.60-1.42]; P = .73). Of the serious adverse events, 5.0% (6 of 121 reported events) in the early tracheostomy group vs 3.4% (4 of 118 reported events) were related to tracheostomy.

CONCLUSIONS AND RELEVANCE: Among patients with severe stroke receiving mechanical ventilation, a strategy of early tracheostomy, compared with a standard approach to tracheostomy, did not significantly improve the rate of survival without severe disability at 6 months. However, the wide confidence intervals around the effect estimate may include a clinically important difference, so a clinically relevant benefit or harm from a strategy of early tracheostomy cannot be excluded.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02377167.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Bösel J, Niesen WD, Salih F, et al. Effect of Early vs Standard Approach to Tracheostomy on Functional Outcome at 6 Months Among Patients With Severe Stroke Receiving Mechanical Ventilation: The SETPOINT2 Randomized Clinical Trial. JAMA. 2022. PMID: 35506515. doi:10.1001/jama.2022.4798

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。